Trial intelligence / Profile preview

Dextromethorphan for Vascular Protection in Heavy Smokers

NCT00605605Phase 4Completed

Sponsor
National Cheng Kung University Hospital
Start
Mar 2005
Primary completion
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in atherosclerosis comparing Dextromethorphan with Placebo (2 arms). Primary endpoint: Endothelial function at 6 months. Started Mar 2005; status: completed.

02

Drugs

dextromethorphan
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT00605605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00605605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call